Laura Naysmith summarises a study of menopausal hormone therapy (also known as HRT), which suggests the treatment is linked with reduce the risk of psychosis relapse in menopausal women.
[read the full story...]
Shuichi Suetani blogs a new study published today in The Lancet Psychiatry, which suggests that those patients who might benefit most from evidence-based guidance are the least represented in clinical trials about ADHD medication. Is it time to reconsider the value we place on RCTs when they do not include the vast majority of people who need help?
[read the full story...]
Amelia Mullett summarises an Australian RCT on the efficacy of a short message service brief contact intervention (SMS-SOS) in reducing repetition of hospital-treated self-harm.
[read the full story...]
Florian Walter summarises a retrospective cohort study published in The Lancet Psychiatry that investigates whether early trajectories of clinical global impression severity can transdiagnostically predict later psychiatric hospitalisation.
[read the full story...]
Kris Deering considers a 2-year prospective observational study published in the Lancet Psychiatry which found strong links between stressful life events and relapse in first-episode psychosis.
[read the full story...]
Ian Hamilton reviews a new controlled interrupted time series study published in The Lancet evaluating the impact of alcohol minimum unit pricing on deaths and hospitalisations in Scotland.
[read the full story...]
Sarah Carr reflects on a recent US study that “perhaps tells us something deeper about the discrimination and stigmatisation in mental health that needs to be tackled.”
[read the full story...]
Elena Opie considers a qualitative study exploring the experiences of vulnerable individuals being assessed under the Mental Health Act.
[read the full story...]
Millie Witcher and Sarah Rowe appraise a randomised controlled trial on the effect of low-intensity treatments for self-harm among people with suicidal ideation, which has some important findings.
[read the full story...]
Joseph Pierre appraises a recent meta-analysis on long-acting injectable antipsychotics compared to oral antipsychotic medication for the maintenance treatment of schizophrenia.
[read the full story...]
